Antigen-specific T Cell Analysis Kit (PBMC), anti-human, REAfinity™

The Antigen-specific T Cell Analysis Kit (PBMC), anti-human, REAfinity® has been developed for fast and easy detection of antigen-reactive T cells by intra- and extracellular staining of T cell activation markers and cytokines. The Kits are available for analysis of T cell responses from PBMC or whole blood samples. Antigenic peptide pools (PepTivators®) or single epitope peptides (MACSpep Single Peptides) must be ordered separately to create an individual T cell stimulation approach. All Kits contain antibodies for the identification of CD4+ and CD8+ T cells, the exclusion of monocytes and

... read more
qualityAssuranceSatisfaction
guaranteed
more »

Related products for Antigen-specific T Cell Analysis Kit (PBMC), anti-human, REAfinity™

Product data and images for Antigen-specific T Cell Analysis Kit (PBMC), anti-human, REAfinity™
Figure 1

Procedure of SARS-CoV-2–reactive T cell analysis: Peripheral blood mononuclear cells (PBMCs) are cultured with the SARS-CoV-2 PepTivator® Peptide Pool or control of choice (e.g. CytoStim™) for a total of 6 hours. Upon activation, cells start to upregulate activation markers and secrete cytokines. After 2 hours of cultivation, Brefeldin A is added to the cells to inhibit transport of proteins to the cellular membrane, thereby enabling intracellular cytokine staining. After the stimulation phase cells are stained with the live/dead marker Viobility 405/452 Fixable Dye. Next, cells are fixed, permeabilized, and stained for lineage and activation markers as well as cytokines using the flow panel provided in the kit. Cells are then analyzed by flow cytometry, e.g., on a MACSQuant® Analyzer.

Figure 2

Hierarchical gating strategy according to figure 3–6.

Figure 3

Pre-gating strategy to identify total CD3+ T cells, CD4+ T cells, and CD8+ T cells: The following flow cytometric analysis was performed with the eight fluorochrome-conjugated antibodies and the live/dead marker that are included in the kit (see data sheet). This allows identification of SARS-CoV-2–reactive T cells in human PBMC samples obtained from convalescent or vaccinated donors. Here, isolated PBMCs of a SARS-CoV-2–reactive donor were left untreated or stimulated with PepTivator® SARS-CoV-2 Prot_S Complete (see data sheet) and analyzed using the MACSQuant® Analyzer 16. The gating strategy allows to determine cell counts and frequencies of total CD3+ SARS-CoV-2–reactive T cells (figure 4) and SARS-CoV-2–reactive T cell subsets (CD4+ T cells (figure 5) and CD8+ T cells (figure 6)). A hierarchical gating strategy is depicted in figure 2.

Figure 4

Identification of total SARS-CoV-2–reactive CD3+ T cells: Gating on total viable CD3+ T cells (figure 3D) allows to determine cell counts and frequencies of total CD3+ SARS-CoV-2–reactive T cells.

Figure 5

Identification of SARS-CoV-2–reactive CD4+ T cells: Gating on total viable CD4+ T cells (figure 3E) allows to determine SARS-CoV-2–reactive CD4+ T cells.

Figure 6

Identification of SARS-CoV-2–reactive CD8+ T cells: Gating on total viable CD8+ T cells (figure 3E) allows to determine SARS-CoV-2–reactive CD8+ T cells.

Specifications for Antigen-specific T Cell Analysis Kit (PBMC), anti-human, REAfinity™
Overview

The Antigen-specific T Cell Analysis Kit (PBMC), anti-human, REAfinity® has been developed for fast and easy detection of antigen-reactive T cells by intra- and extracellular staining of T cell activation markers and cytokines. The Kits are available for analysis of T cell responses from PBMC or whole blood samples. Antigenic peptide pools (PepTivators®) or single epitope peptides (MACSpep Single Peptides) must be ordered separately to create an individual T cell stimulation approach. All Kits contain antibodies for the identification of CD4+ and CD8+ T cells, the exclusion of monocytes and B cells, as well as the staining of activation markers and intracellular cytokines. Furthermore, a positive control (CytoStim™), a live/dead marker (Viobility™ 405/452 Fixable Dye), Brefeldin A, and the buffers for fixation and permeabilization of cells after stimulation (Inside Fix and Inside Perm) are included. The use of 96-well cell culture plates enables the analysis of multiple samples in parallel. The flow cytometry panel and the protocol have been optimized to ensure a comprehensive and efficient analysis of antigen-reactive T cells in the context of cancer, infections, autoimmunity, and more.

Please note: The Antigen-specific T Cell Analysis Kits do not contain peptide stocks in order to allow flexible combination of the Kits with any peptide of interest.

Detailed product information
Background information

T lymphocytes execute and control immunological reactions with a repertoire of cytokines, cytotoxic substances, and other mediators. The quantitative and qualitative analysis of CD4+ T cells and CD8+ T cells specifically recognizing and reacting towards a defined antigen provide important information to understand their function in various immunological situations. The presence of these cells indicate an infected or convalescent donor and may also allow conclusions on disease progress, severity, and immune status, e.g. in cancer or autoimmune patients1-8. Antigen-reactive T cells can thereby be identified and characterized by analyzing their effector function, e.g., by their upregulation of activation markers and production of cytokines. The Antigen-specific T cell Analysis Kits represent a sensitive and precise multiparameter assay to efficiently asses antigen-reactivity of T cells.

Applications
  • Rapid detection of CD4+ and CD8+ T cells reactive towards any antigen of interest
  • Phenotypical characterization of activated T cells after stimulation with PepTivator® Peptide Pools or MACSpep Single Peptides by flow cytometry
  • Immune monitoring of antigen-specific T cells
  • Research and monitoring of infection- and vaccine-specific T cell responses in individuals
Resources for Antigen-specific T Cell Analysis Kit (PBMC), anti-human, REAfinity™
Documents and Protocols
Certificates

To access a Certificate of Analysis (CoA) follow the link below and enter the specific lot of your product.

Get certificate

Should you wish to request additional documentation, such as a Safety Data Sheet (SDS) in other languages than English or Swedish, an SDS-replacement document, or a Certificate of Origin (CoO), please direct your inquiry to your local technical support team.

Contact technical support

To access a Safety Data Sheet for a hazardous product or component in English or Swedish language, follow the link below and enter the catalog number of the product.

Please note, that the Safety Data Sheet has a cover sheet only in English language.

Should you wish a Safety Data Sheet (SDS) in other languages than English or Swedish, please contact Technical Support.

Get Safety Data Sheet

Citations for Antigen-specific T Cell Analysis Kit (PBMC), anti-human, REAfinity™
Publications
  1. Braun, J. et al. (2020) SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19. Nature 587 (7833): 270-274
  2. Dan, J. et al. (2021) Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. Science 371: eabf4063
  3. Meckiff, J. et al. (2020) Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4+ T Cells in COVID-19. Cell 183 (5): 1340-1353
  4. Jarjour, N. N. et al. (2021) T Cell Memory: Understanding COVID-19. Immunity 54 (1): 14-18
  5. Thieme, C. J. et al. (2020) Robust T Cell Response Toward Spike, Membrane, and Nucleocapsid SARS-CoV-2 Proteins Is Not Associated with Recovery in Critical COVID-19 Patients. Cell Rep Med. 1 (6): 100092
  6. Bacher, P. et al. (2020) Low avidity CD4+ T cell responses to SARS-CoV-2 in unexposed individuals and humans with severe COVID-19. Immunity 53: 1258-1271
  7. Swadling, L. et al. (2020) T cells in COVID-19 - united in diversity. Nat Immunol 21 (11): 1307-1308
  8. Kusnadi, A. et al. (2021) Severely ill COVID-19 patients display augmented functional properties in SARS-CoV-2-reactive CD8+ T cells. Sci Immunol 6: eabe4782

You have previously chosen International as your location.
What do you want to do?